SARS News and Research

RSS

Aromatherapy may alleviate nurses’ on-the-job stress, study suggests

Even under normal circumstances, nursing can be a stressful profession. The COVID-19 pandemic only exacerbates it.

3 May 2020

AHA awards grants to 12 teams for fast-tracked heart and brain health research related to COVID-19

Less than a month after issuing a rapid response call for scientific research proposals for fast-tracked studies of the effects of COVID-19 on the body's cardiovascular and cerebrovascular systems, the American Heart Association has awarded $1.2 million in grants to teams at 12 institutions across the U.S. to begin this unprecedented work.

2 May 2020

Avacta Group plc forms COVID-19 antigen diagnostic collaboration with Adeptrix

Avacta Group plc is pleased to announce that it has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test.

From Avacta Life Sciences Ltd. 1 May 2020

COVID-19 transmission model shows social distancing was effective in China

Most countries are at a standstill, with social distancing and physical distancing measures in place to reduce the spread of the novel coronavirus. Now, a new transmission model of the coronavirus disease (COVID-19) confirms that social distancing measures were effective in Wuhan City, the epicenter of the coronavirus pandemic, and Shanghai in China.

1 May 2020

COVID-19 lockdown affecting UK adult mental health

As the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) took a firmer hold on the UK, the government introduced a lockdown on March 24, 2020, in an all-out attempt to ‘flatten the curve’ of infections. While the number of deaths has fallen in response, a new study published in the journal medRxiv in April 2020 reports that the pandemic is also associated with increased anxiety and depression in UK adults experiencing isolation.

30 Apr 2020

Spike protein analysis from India's first SARS-CoV-2

A new study published on the preprint server bioRxiv analyzes viral spike protein sequences from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak in West Bengal, India, comparing them with sequences from other Indian states and Wuhan, China.

30 Apr 2020

New clinical trial to assess whether hypertension drug may reduce COVID-19 severity

Researchers at University of California San Diego School of Medicine have launched a clinical trial to investigate whether a drug approved for treating high blood pressure, heart failure and diabetic kidney disease might also reduce the severity of COVID-19 infections, lowering rates for intensive care unit admissions, the use of mechanical ventilators and all-cause mortality.

30 Apr 2020

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a "magic bullet" to prevent and cure COVID-19. And the medicines can - if used rashly - have serious side effects.

30 Apr 2020

Scientists generate molecular models of compounds relevant for COVID-19

The discovery of suitable drugs that could help treat diseases is a long process. However, computer-aided drug design and simulation could speed up the process and also increase the possibilities say experts. This form of drug design and simulation could soon be the gold standard in drug development.

30 Apr 2020

New database catalogs peptides that may halt SARS-CoV-2 cell infection

In the quest for a highly specific and tailored treatment strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent publication available on the preprint server bioRxiv describes a repository of designed peptides that interfere with the early stages of viral invasion process.

30 Apr 2020

Testing sewage could be useful in monitoring COVID-19 circulation in the population

Researchers in Italy have demonstrated the potential value of sewage system monitoring for studying trends in the circulation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

30 Apr 2020

New Elsevier Coronavirus Research Hub offers free access to biomedical research tools, content

Elsevier, a global leader in information analytics specializing in science and health, is offering free access to a unique set of biomedical research tools and content to help researchers and life science companies accelerate efforts to address the current pandemic.

30 Apr 2020

ProteoGenix launches first Human Immune COVID-19 antibody library

ProteoGenix, a global leader in antibody production, is pleased to announce the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.

30 Apr 2020

New mathematical model precisely estimates the death toll linked to COVID-19

A Rutgers engineer has created a mathematical model that accurately estimates the death toll linked to the COVID-19 pandemic in the United States and could be used around the world.

30 Apr 2020

Newly launched clinical trial can help treat COVID-19 patients

Research by University of Iowa virologist Wendy Maury, PhD, has helped facilitate the launch of a new clinical trial in the United Kingdom of a drug that might help treat patients with COVID-19.

30 Apr 2020

Temple University Hospital is offering COVID-19 clinical trials, investigational treatments options

Temple University Hospital is now participating in a variety of clinical trials that are testing investigational treatment options for patients diagnosed with the novel coronavirus, or COVID-19.

30 Apr 2020

Remdesivir shows powerful activity against SARS-CoV-2 in Vitro

Remdesivir is an antiviral first developed by Gilead in 2014 as a treatment for Ebola and Marburg viruses. However, scientists explored its possibilities as a broad-spectrum drug when it proved effective against SARS-CoV and MERS-CoV, coronaviruses which were responsible for earlier outbreaks.

30 Apr 2020

Online searches for unproven therapies for COVID-19

A new observational study by a group of scientists explores the rise in the public's fear-driven interest in unproven therapies for COVID-19, particularly chloroquine and hydroxychloroquine, by tracking the internet searches relating to the purchase of drugs in news reports or publicized by public figures. They conclude: "Stay grounded in evidence and fight misinformation." The research letter and accompanying editorial comment are published in the journal JAMA Internal Medicine.

29 Apr 2020

Antibody produced by llamas shows promise against SARS-CoV-2

The hunt for an effective treatment for COVID-19 has led one team of researchers to find an improbable ally for their work: a llama named Winter.

29 Apr 2020

New clinical trial launched to study if convalescent plasma can treat COVID-19

Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have launched a new clinical trial to study if convalescent plasma- taken from people who have recovered from COVID-19 - is effective in treating the disease.

29 Apr 2020